Press Releases
2012
  • 07/20/2012 Kyprolis™ (carfilzomib) for Injection Receives Accelerated Approval from FDA for Advanced Multiple Myeloma
  • 7/10/2012 Multiple Myeloma Research Foundation (MMRF) Welcomes Renowned Leaders to Board of Directors
  • 4/10/2012 Multiple Myeloma Research Consortium (MMRC) and Synta Pharmaceuticals Announce First Patient in Clinical Trial in Multiple Myeloma
  • 4/9/2012 The Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) Appoint Michael N. Needle, M.D., Chief Medical Officer April
  • 4/2/2012 The Multiple Myeloma Research Foundation (MMRF) and Translational Genomics Research Institute Announce Innovative Molecular Profiling and Biobanking Collaboration for Landmark Multiple Myeloma Study
  • 1/19/2012 The Multiple Myeloma Research Foundation (MMRF) Releases White Paper Outlining the Increasingly Important Role of Non-Profit Organizations in Drug Development
2011
  • 12/22/2011 Multiple Myeloma Research Consortium (MMRC) Opens Record-Breaking Number of Trials in 2011 to Advance Multiple Myeloma Treatments
  • 12/21/2011 Multiple Myeloma Research Consortium (MMRC) Honors Dr. Ravi Vij, Washington University with 2011 Center of the Year Award
  • 12/19/2011 The Multiple Myeloma Research Foundation (MMRF) Announces Four Leading Academic Cancer Centers as Clinical Sites for Landmark Study
  • 12/14/2011 The Multiple Myeloma Research Foundation (MMRF) and Onyx Pharmaceuticals Announce Multi-Year Collaboration to Accelerate Personalized Medicine Approaches for Multiple Myeloma
  • 12/13/2011 Multiple Myeloma Research Consortium (MMRC) Presents New Data Affirming Success in Accelerating Drug Development Timelines
  • 12/6/2011 Multiple Myeloma Research Consortium to Present Data in Eight Oral or Poster Sessions at 53rd American Society of Hematology (ASH) Annual Meeting
  • 12/2/2011 Multiple Myeloma Research Consortium (MMRC) Welcomes the Barbara Ann Karmanos Cancer Institute as Member Institution
  • 9/29/2011 Multiple Myeloma Research Foundation (MMRF) Announces Millennium as First Industry Partner in Innovative Collaboration to Advance Personalized Medicine for Multiple Myeloma
  • 9/20/2011 Multiple Myeloma Research Foundation (MMRF) Announces First Patient Enrolled in Landmark 1000-Patient Study, with Four World-Class Cancer Centers as First Clinical Sites
  • 9/14/2011 Tragara Pharmaceuticals and the Multiple Myeloma Research Foundation Initiate Phase I Clinical Study of TG02 in Multiple Myeloma Patients
  • 8/3/2011 MMRF Announces Launch of Carfilzomib Expanded Access Program for Patients with Relapsed and Refractory Multiple Myeloma in Partnership with Onyx Pharmaceuticals
  • 6/9/2011 Multiple Myeloma Research Foundation (MMRF) Welcomes Michael Reinert to Board of Directors
  • 6/7/2011 Kathy Giusti and MMRF Featured in Harvard Business Review
  • 5/5/2011 Multiple Myeloma Research Foundation (MMRF) and Astellas Pharma Global Development Enter into Joint Collaboration to Accelerate Drug Development for Myeloma Patients
  • 4/9/2011 Multiple Myeloma Research Foundation (MMRF) Saddened by Loss of Dear Friend and Board Member Edward Jay Phillips
  • 3/26/2011 Multiple Myeloma Research Foundation (MMRF) Mourns Loss of Geraldine Ferraro
  • 3/23/2011 Multiple Myeloma Research Foundation Announces Publication of First Whole-Genome Sequence Analysis for Multiple Myeloma
  • 3/16/2011 The Multiple Myeloma Research Foundation (MMRF) to Host Clinical Insights Patient Symposium in Collaboration with the John Theurer Cancer Center
  • 1/12/2011 Multiple Myeloma Research Foundation (MMRF) and Synta Pharmaceuticals Enter into Joint Collaboration to Accelerate Drug Development for Myeloma Patients
2010
  • 12/30/2010 Multiple Myeloma Research Foundation (MMRF) Saddened by Loss of Dear Friend and Former Board Member Bob DeBaun
  • 12/22/2010 Multiple Myeloma Research Consortium (MMRC) Welcomes Baylor Charles A. Sammons Cancer Center at Dallas, Sarah Cannon Research Institute, and Virginia Cancer Specialists as Member Institutions
  • 12/6/2010 Multiple Myeloma Research Consortium (MMRC) Accelerates Clinical Trial Process
  • 12/3/2010 Multiple Myeloma Research Consortium (MMRC) Honors University of Michigan with 2010 Center of the Year Award
  • 11/30/2010 Intellikine and the Multiple Myeloma Research Consortium Initiate Phase I Trial of Targeted Drug INK128
  • 9/8/2010 Multiple Myeloma Research Foundation (MMRF) Welcomes Nodality President and CEO David Parkinson, M.D. to Board of Directors
  • 8/12/2010 Astex and Multiple Myeloma Research Consortium (MMRC) Announce Start of Phase II Clinical Study of AT7519 in Multiple Myeloma
  • 8/2/2010 Multiple Myeloma Research Consortium (MMRC) and Mount Sinai School of Medicine Announce Research Collaboration
  • 7/29/2010 The Multiple Myeloma Research Foundation (MMRF) Names Walter Capone Chief Operating Officer
  • 7/28/2010 Multiple Myeloma Research Consortium (MMRC) Helps to Advance Clinical Development of Carfilzomib
  • 7/26/2010 Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data from Phase 2b Study
  • 6/1/2010 Multiple Myeloma Research Consortium (MMRC) Announces Data Presentations at 46th Annual American Society of Clinical Oncology (ASCO) Annual Meeting
  • 4/20/2010 Multiple Myeloma Research Consortium (MMRC) Genomics Initiative Provides First In-depth Look at Multiple Myeloma Genome
  • 4/6/2010 Multiple Myeloma Research Consortium (MMRC) Initiates Phase IB/II Clinical Trial of Treanda in Combination with Revlimid and Dexamethasone in Patients with Relapsed Multiple Myeloma
  • 3/26/2010 Multiple Myeloma Research Foundation (MMRF) Welcomes MasterCard President Chris McWilton to Board of Directors